scholarly journals Minimally invasive antral membrane balloon elevation as an alternative approach to sinus augmentation with simultaneous implant placement. A review and case series

2017 ◽  
Vol 28 ◽  
pp. 478-478
Keyword(s):  
Minimally Invasive ◽  
Case Series ◽  
Sinus Augmentation ◽  
Implant Placement ◽  
Alternative Approach

scholarly journals Removal of Inflammatory Tissue/Product by Sinus Membrane Puncturing during Lateral Sinus Augmentation in Asymptomatic Patients with Severely Opacified Sinuses: A Case Series

2021 ◽  
Vol 11 (24) ◽  
pp. 11831
Author(s):  
Won-Bae Park ◽  
Jung Soo Park ◽  
Ji-Young Han ◽  
Seung-Il Shin ◽  
Hyun-Chang Lim
Keyword(s):  
Case Series ◽  
Lateral Sinus ◽  
Sinus Augmentation ◽  
Saline Irrigation ◽  
Implant Placement ◽  
Product Removal ◽  
Posterior Maxilla ◽  
Sinus Membrane ◽  
Tissue Product ◽  
Inflammatory Tissue

It is generally recommended that severe sinus membrane (SM) thickening should be treated prior to maxillary sinus augmentation (MSA), but during lateral MSA, inflammatory tissue/product may be removed by puncturing the SM. The present case report demonstrates surgical experience of lateral MSA with simultaneous inflammatory tissue/product removal for sinuses with severe opacification. In three patients requiring dental implant placement in the posterior maxilla, severe SM thickening was observed, but they were asymptomatic. The SM was gently elevated, followed by puncturing the SM, removing inflammatory tissue via the punctured site, draining, and thorough saline irrigation. Then, bone grafting and implant placement were performed with extra care not to spread bone substitute material into the punctured area. The postoperative pain following this procedure was more severe as compared to conventional MSA. Nasal bleeding was reported for 2–3 days. All implants were successfully integrated and demonstrated adequate function. Tissue samples retrieved during the surgery showed advanced inflammatory cell infiltration. The follow-up cone-beam computed tomographic scans revealed a significant reduction in SM thickening. In conclusion, inflammatory tissue/product removal by puncturing the SM can be applied during lateral MSA. However, more data should be needed due to the empirical nature of the present outcomes.

scholarly journals The use of bone block allografts in sinus augmentation, followed by delayed implant placement: A case series

2013 ◽  
Vol 4 (1) ◽  
pp. 13 ◽  
Author(s):  
Massimiliano Ricci ◽  
Guerino Caso ◽  
Enrico Santi ◽  
Tonelli Paolo ◽  
Barone Antono ◽  
...  
Keyword(s):  
Case Series ◽  
Bone Block ◽  
Sinus Augmentation ◽  
Implant Placement ◽  
Delayed Implant Placement

Minimally Invasive Surgical Placements of Nonsubmerged Dental Implants: A Case Series Report, Evaluation of the Surgical Technique and Complications

2011 ◽  
Vol 37 (5) ◽  
pp. 579-587 ◽  
Author(s):  
Yong Loong Tee
Keyword(s):  
Surgical Technique ◽  
Minimally Invasive ◽  
Dental Implants ◽  
Case Series ◽  
Surgical Implant ◽  
Flap Technique ◽  
Minimally Invasive Surgical ◽  
Implant Placement ◽  
Case Series Report ◽  
Series Report

Minimally invasive surgical implant placement has numerous advantages over conventional open flap technique. A series of cases is described here explaining the use of the tissue punch with discussion of the complications and management.

Human Histologic Evaluation of the Use of the Dental Putty for Bone Formation in the Maxillary Sinus: Case Series

2012 ◽  
Vol 38 (4) ◽  
pp. 391-398 ◽  
Author(s):  
David M. Kim ◽  
Myron Nevins ◽  
Marcelo Camelo ◽  
Marc L. Nevins ◽  
Peter Schupbach ◽  
...  
Keyword(s):  
Bone Formation ◽  
Maxillary Sinus ◽  
Case Series ◽  
Osteotomy Site ◽  
Collagen Membrane ◽  
Loose Connective Tissue ◽  
Sinus Augmentation ◽  
Implant Placement ◽  
Histologic Evaluation ◽  
Mucoperiosteal Flap

A proof-of-principle study was conducted to assess the safety and efficacy of dental putty as an alternative sinus augmentation biomaterial. Six healthy patients requiring a total of 10 sinus augmentations received sinus augmentations. All patients volunteered and signed an informed consent based on the Helsinki declaration of 1975, as revised in 2000. The sinus augmentation was performed under local anesthesia with a mucoperiosteal flap elevated to expose the buccal wall of the maxillary sinus. The space was then filled with the dental putty in several increments, and the window was covered with an absorbable collagen membrane. Biopsies were harvested from all 10 treated sinuses using a 3-mm trephine bur at the time of implant placement at either 6 or at 9 months after sinus augmentation. All patients completed the study without complications, except for 1 patient who reported fistulas at 1 and 2 months after the surgery. Clinical reentry revealed that regenerated bone on the osteotomy site was soft and immature. The ground sections of the biopsied cores revealed minimum amounts of trabeculation surrounded by an abundant array of irregular-shaped residual alloplastic particles embedded in loose connective tissue. The present study's findings revealed inadequate bone formation, although the material appears to be bioinert as there is no elicitation of inflammatory response.

Dental Implant Placement in Patients with a History of Medications Related to Osteonecrosis of the Jaws: A Systematic Review

2020 ◽  
Author(s):  
Judd Sher ◽  
Kate Kirkham-Ali ◽  
Denny Luo ◽  
Catherine Miller ◽  
Dileep Sharma
Keyword(s):  
Systematic Review ◽  
At Risk ◽  
Drug Therapy ◽  
Dental Implant ◽  
Case Series ◽  
Cochrane Central Register ◽  
Bisphosphonate Treatment ◽  
Implant Placement ◽  
Increased Risk ◽  
History Of

The present systematic review evaluates the safety of placing dental implants in patients with a history of antiresorptive or antiangiogenic drug therapy. The Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) guidelines were followed. PubMed, Cochrane Central Register of Controlled Trials, Scopus, Web of Science, and OpenGrey databases were used to search for clinical studies (English only) to July 16, 2019. Study quality was assessed regarding randomization, allocation sequence concealment, blinding, incomplete outcome data, selective outcome reporting, and other biases using a modified Newcastle-Ottawa scale and the Joanna Briggs Institute critical appraisal checklist for case series. A broad search strategy resulted in the identification of 7542 studies. There were 28 studies reporting on bisphosphonates (5 cohort, 6 case control, and 17 case series) and one study reporting on denosumab (case series) that met the inclusion criteria and were included in the qualitative synthesis. The quality assessment revealed an overall moderate quality of evidence among the studies. Results demonstrated that patients with a history of bisphosphonate treatment for osteoporosis are not at increased risk of implant failure in terms of osseointegration. However, all patients with a history of bisphosphonate treatment, whether taken orally for osteoporosis or intravenously for malignancy, appear to be at risk of ‘implant surgery-triggered’ MRONJ. In contrast, the risk of MRONJ in patients treated with denosumab for osteoporosis was found to be negligible. In conclusion, general and specialist dentists should exercise caution when planning dental implant therapy in patients with a history of bisphosphonate and denosumab drug therapy. Importantly, all patients with a history of bisphosphonates are at risk of MRONJ, necessitating this to be included in the informed consent obtained prior to implant placement. The James Cook University College of Medicine and Dentistry Honours program and the Australian Dental Research Foundation Colin Cormie Grant were the primary sources of funding for this systematic review.

Aumento de coroa estética sem elevação de retalho – abordagem minimamente invasiva

2020 ◽  
Vol 12 (45) ◽  
pp. 34-39
Author(s):  
Flavia Sukekava ◽  
Julia Helena Luiz ◽  
Paloma Palma ◽  
Jaques Luiz
Keyword(s):  
Minimally Invasive ◽  
Correct Diagnosis ◽  
Case Series ◽  
Minimally Invasive Techniques ◽  
Bone Removal ◽  
Use Of Technology ◽  
Treatment Plans ◽  
Invasive Techniques ◽  
Crown Lengthening ◽  
Gummy Smile

Gummy smile is a characteristic in which the patient exposes more than 2 mm of keratinized gingiva in forced smile. With a multifactorial cause, its correct planning depends directly on the correct diagnosis. Usually, the procedures that involve manipulation and the enlargement of the aesthetical crown lengthening are surgical. The objective of this case series was to show the advantages of surgical crown augmentation surgery in aesthetic areas with minimally invasive techniques. Three cases of gummy smile were presented, with different treatment plans and techniques for execution. In the 3 cases, bone removal was performed with piezoelectric ultrasound, which made the postoperative more comfortable for patients. These cases illustrate the use of technology to reduce morbidity in patients who need to undergo bone removal to treat gingival smile.

Sign in / Sign up

Export Citation Format

Share Document